SANUWAVE Health, Inc. Common Stock (SNWV) Stock Price

SNWVStock

$4.67−88.98%52W

Market Cap$40.22M

P/E3.47x

PEG Ratio—

Div yield—

Beta1.43

SNWV Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-92.22%

Price vs S&P 500 (4W)-27.45%

VGM Score53.34

P/E Ratio (Annual)3.47x

P/CF (Annual)10.59x

Book Value / Share (Quarterly)$0.21

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)38.05%

Cash Flow / Share (Quarterly)$0.45

Price vs S&P 500 (YTD)-97.15%

Gross Margin (TTM)76.74%

Net Profit Margin (TTM)36.21%

EPS (TTM)$1.77

10-Day Avg Trading Volume0.07M

EPS Excl Extra (TTM)$1.77

Revenue Growth (5Y)61.12%

EPS (Annual)$1.30

ROI (Annual)50.10%

Gross Margin (Annual)77.11%

Net Profit Margin (5Y Avg)-93.37%

Cash / Share (Quarterly)$1.25

P/E Basic Excl Extra (TTM)2.56x

Revenue Growth QoQ (YoY)2.97%

P/E Normalized (Annual)3.47x

ROA (Last FY)31.63%

Revenue Growth TTM (YoY)22.49%

EBITD / Share (TTM)$0.35

Operating Margin (TTM)4.88%

Cash Flow / Share (Annual)$0.23

P/B Ratio22.32x

P/B Ratio (Quarterly)80.85x

Net Income / Employee (Annual)$214,800

EV / Revenue (TTM)1.15x

Net Interest Coverage (TTM)0.30x

ROA (TTM)44.87%

EV / EBITDA (TTM)16.42x

EPS Incl Extra (Annual)$1.30

Current Ratio (Annual)1.38x

Quick Ratio (Quarterly)0.92x

3-Month Avg Trading Volume0.17M

52-Week Price Return-88.98%

EV / Free Cash Flow (Annual)26.28x

P/E Incl Extra (TTM)2.56x

Revenue / Employee (TTM)$806,000

Tangible BV / Share (Quarterly)$2.07

P/S Ratio (Annual)0.93x

Asset Turnover (Annual)1.18x

52-Week High$44.51

Operating Margin (5Y Avg)-33.61%

EPS Excl Extra (Annual)$1.30

CapEx CAGR (5Y)105.57%

26-Week Price Return-80.29%

Quick Ratio (Annual)0.97x

13-Week Price Return-71.94%

Total Debt / Equity (Annual)13.56x

Current Ratio (Quarterly)1.31x

Enterprise Value$50.82M

Revenue / Share Growth (5Y)3.84%

Asset Turnover (TTM)1.24x

Revenue / Employee (Annual)$800,900

Inventory Turnover (Annual)2.00x

Pretax Margin (Annual)27.01%

Cash / Share (Annual)$1.39

3-Month Return Std Dev138.93%

Gross Margin (5Y Avg)71.71%

Net Income / Employee (TTM)$291,800

ROE (Last FY)729.65%

Net Interest Coverage (Annual)0.73x

EPS Basic Excl Extra (Annual)$1.30

P/FCF (TTM)10.21x

Receivables Turnover (TTM)8.99x

EV / Free Cash Flow (TTM)13.19x

Total Debt / Equity (Quarterly)11.19x

EPS Incl Extra (TTM)$1.77

Receivables Turnover (Annual)10.07x

ROI (TTM)20.31%

P/S Ratio (TTM)0.93x

Pretax Margin (5Y Avg)-93.26%

Revenue / Share (Annual)$4.85

Tangible BV / Share (Annual)$-0.10

Forward P/E5.62x

Price vs S&P 500 (52W)-107.54%

P/E Ratio (TTM)2.56x

Year-to-Date Return-84.33%

5-Day Price Return-0.95%

EPS Normalized (Annual)$1.30

ROA (5Y Avg)-77.17%

Net Profit Margin (Annual)26.82%

Month-to-Date Return-24.23%

Cash Flow / Share (TTM)$-0.08

EBITD / Share (Annual)$0.57

Operating Margin (Annual)9.70%

LT Debt / Equity (Annual)10.08x

P/CF (TTM)7.09x

P/E Excl Extra (TTM)2.56x

LT Debt / Equity (Quarterly)8.15x

EPS Basic Excl Extra (TTM)$1.77

P/TBV (Quarterly)88.90x

P/B Ratio (Annual)158.07x

Inventory Turnover (TTM)1.82x

Pretax Margin (TTM)36.40%

Book Value / Share (Annual)$0.19

Price vs S&P 500 (13W)-73.89%

Beta1.43x

P/FCF (Annual)21.22x

Revenue / Share (TTM)$5.16

ROE (TTM)270.18%

52-Week Low$4.50

vGradeB

gGradeB

mGradeF

vgmGradeC

SNWV Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2025	Mar 26, 2026	$0.17	$0.03	-82.35%(-$0.14)
Q3 2025	Nov 7, 2025	$0.32	$0.46	+43.75%(+$0.14)
Q2 2025	Aug 7, 2025	-$0.09	$0.01	+111.11%(+$0.10)

SNWV Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
SNWVSANUWAVE Health, Inc. Common Stock	B	B	F	$4.67
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About SANUWAVE Health, Inc. Common Stock

SANUWAVE Health develops noninvasive ultrasound and shock wave technology for regenerative medicine, with a focus on wound healing. The company's two primary products, UltraMIST and PACE, are the only FDA-approved directed energy systems for this indication. This regulatory exclusivity provides a differentiated market position in the specialized wound care sector.